Pharmacists may help identify predictable ICI toxicities to improve cancer therapy
A recent study has shown the necessary assistance pharmacists could provide in identifying predictable toxicities of immune checkpoint inhibitors (ICIs) that are related to gastrointestinal, endocrine, and dermatological toxicities, and fatigue.